Japan Shoots For ‘Zero’ Device Lag With Review Time Targets
This article was originally published in Clinica
Japan aims to eliminate the country’s notorious time lag associated with the regulatory approval of medical devices, by introducing new measures to speed up the review process. It is looking to adopt a different approach in which the speed will be determined by how urgent the review of the products is, or how urgently the products are needed.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.